1. Home
  2. MLSS vs CDT Comparison

MLSS vs CDT Comparison

Compare MLSS & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.28

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

CDT

Conduit Pharmaceuticals Inc.

SELL

Current Price

$3.36

Market Cap

22.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MLSS
CDT
Founded
1989
2019
Country
United States
United States
Employees
N/A
6
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
22.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
MLSS
CDT
Price
$0.28
$3.36
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
996.3K
98.0K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,973,982.00
N/A
Revenue This Year
$12.64
N/A
Revenue Next Year
$8.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.99
N/A
52 Week Low
$0.22
$0.37
52 Week High
$1.11
$11.00

Technical Indicators

Market Signals
Indicator
MLSS
CDT
Relative Strength Index (RSI) 47.90 50.08
Support Level $0.27 $3.18
Resistance Level $0.30 $4.50
Average True Range (ATR) 0.02 1.10
MACD -0.00 -0.21
Stochastic Oscillator 38.04 11.98

Price Performance

Historical Comparison
MLSS
CDT

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.

Share on Social Networks: